CLDN5 and liver cancer: Furthermore, to investigate the correlation of CD34+CLDN5+ ECs with overall survival duration in primary liver cancer patients, mIHC were performed on tissue microarrays containing 66 primary liver cancer specimens with long-term clinical follow-up data.